Philip D. McLellan - 15 Nov 2024 Form 3 Insider Report for QuidelOrtho Corp (QDEL)

Role
Chief Operations Officer
Signature
/s/ Jennifer Ahn, attorney-in-fact for Philip D. McLellan
Issuer symbol
QDEL
Transactions as of
15 Nov 2024
Net transactions value
$0
Form type
3
Filing time
22 Nov 2024, 16:24:36 UTC
Next filing
31 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding QDEL Common Stock 5,549 15 Nov 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding QDEL Non-Qualified Stock Options 15 Nov 2024 Common Stock 1,678 $248.41 Direct F1
holding QDEL Non-Qualified Stock Options 15 Nov 2024 Common Stock 1,352 $254.00 Direct F2
holding QDEL Non-Qualified Stock Options 15 Nov 2024 Common Stock 4,507 $103.36 Direct F3
holding QDEL Non-Qualified Stock Options 15 Nov 2024 Common Stock 5,836 $88.67 Direct F4
holding QDEL Non-Qualified Stock Options 15 Nov 2024 Common Stock 9,714 $39.08 Direct F5
holding QDEL Restricted Stock Units 15 Nov 2024 Common Stock 338 Direct F6, F7
holding QDEL Restricted Stock Units 15 Nov 2024 Common Stock 420 Direct F7, F8
holding QDEL Restricted Stock Units 15 Nov 2024 Common Stock 2,254 Direct F7, F9
holding QDEL Restricted Stock Units 15 Nov 2024 Common Stock 1,693 Direct F7, F10
holding QDEL Restricted Stock Units 15 Nov 2024 Common Stock 2,009 Direct F7, F11
holding QDEL Restricted Stock Units 15 Nov 2024 Common Stock 634 Direct F7, F11
holding QDEL Restricted Stock Units 15 Nov 2024 Common Stock 3,891 Direct F7, F12
holding QDEL Restricted Stock Units 15 Nov 2024 Common Stock 9,713 Direct F7, F13
holding QDEL Restricted Stock Units 15 Nov 2024 Common Stock 4,749 Direct F7, F14
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vested in full.
F2 1,014 shares are vested in full; the remaining 338 shares will vest on February 1, 2025.
F3 2,253 shares are vested in full: the remaining 2,254 shares will vest in equal installments on January 31, 2025 and January 31, 2026.
F4 1,945 shares are vested in full; 1,945 shares will vest on April 26, 2025 and 1,946 shares will vest on April 26, 2026.
F5 9,714 shares will vest in equal installments on April 22, 2025, April 22, 2026 and April 22, 2027.
F6 338 shares will vest on February 1, 2025.
F7 Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
F8 420 shares will vest on May 25, 2025.
F9 2,254 shares will vest in equal installments on January 31, 2025 and January 31, 2026.
F10 846 shares will vest on January 31, 2025 and 847 shares will vest on January 31, 2026.
F11 Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and will occur according to the elected deferral schedule.
F12 1,945 shares will vest on April 26, 2025 and 1,946 shares will vest on April 26, 2026.
F13 3,237 shares will vest on April 22, 2025; 6,476 shares will vest in equal installments on April 22, 2026 and April 22, 2027.
F14 4,749 shares will vest on June 30, 2025.

Remarks:

Exhibit 24.1 - Power of Attorney